DRUG SAFETY ALERT!

The Indian Pharmacopoeia Commission (IPC) has issued a Drug Safety Alert regarding an adverse drug reaction (ADR) identified through the PvPI database.
Suspected Drug: Sulfamethoxazole + Trimethoprim
Indications: Urinary Tract Infection, Respiratory Tract Infection (including Bronchitis, Pneumonia), infections in Cystic Fibrosis, Melioidosis, Listeriosis, Brucellosis, Granuloma Inguinale, Otitis Media, Skin Infection, Pneumocystis Carinii Pneumonia.
Adverse Drug Reaction (ADR) Observed: Leukopenia

To Healthcare Professionals, Patients, and Consumers:
We urge everyone to closely monitor for the possibility of Leukopenia if you are using Sulfamethoxazole + Trimethoprim for any of the indicated conditions.
If you encounter this or any other adverse drug reaction:

Please report it to the NCC-PvPI, IPC by filling out the Suspected Adverse Drug Reactions Reporting Form/Medicines Side Effect Reporting Form for Consumer.

⬇️ Download the form here: http://www.ipc.gov.in
📞 You can also report by calling the PvPI Helpline No.: 1800-180-3024
Your vigilance helps us ensure drug safety for all. Please share this information to spread awareness!